133 related articles for article (PubMed ID: 17105959)
21. Exploratory behaviour of rats in the elevated plus-maze is differentially sensitive to inactivation of the basolateral and central amygdaloid nuclei.
Moreira CM; Masson S; Carvalho MC; Brandão ML
Brain Res Bull; 2007 Mar; 71(5):466-74. PubMed ID: 17259015
[TBL] [Abstract][Full Text] [Related]
22. Increased anxiety-related behavior in male and female adult rats following early and late adolescent exposure to 3,4-methylenedioxymethamphetamine (MDMA).
Kolyaduke OV; Hughes RN
Pharmacol Biochem Behav; 2013 Feb; 103(4):742-9. PubMed ID: 23262299
[TBL] [Abstract][Full Text] [Related]
23. In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA), but not 3,4-methylenedioxymethamphetamine (MDMA), leads to long-lasting deficits in serotonin transporter function.
Callaghan PD; Owens WA; Javors MA; Sanchez TA; Jones DJ; Irvine RJ; Daws LC
J Neurochem; 2007 Feb; 100(3):617-27. PubMed ID: 17181558
[TBL] [Abstract][Full Text] [Related]
24. Repeated weekly exposure to MDMA, methamphetamine or their combination: long-term behavioural and neurochemical effects in rats.
Clemens KJ; Cornish JL; Hunt GE; McGregor IS
Drug Alcohol Depend; 2007 Jan; 86(2-3):183-90. PubMed ID: 16884865
[TBL] [Abstract][Full Text] [Related]
25. An analysis of spontaneous behavior following acute MDMA treatment in male and female rats.
Pálenícek T; Hlinák Z; Bubeníková-Valesová V; Votava M; Horácek J
Neuro Endocrinol Lett; 2007 Dec; 28(6):781-8. PubMed ID: 18063949
[TBL] [Abstract][Full Text] [Related]
26. A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy").
Thompson MR; Callaghan PD; Hunt GE; Cornish JL; McGregor IS
Neuroscience; 2007 May; 146(2):509-14. PubMed ID: 17383105
[TBL] [Abstract][Full Text] [Related]
27. Endocrine and behavioral effects of neuromedin S.
Jászberényi M; Bagosi Z; Thurzó B; Földesi I; Telegdy G
Horm Behav; 2007 Dec; 52(5):631-9. PubMed ID: 17900576
[TBL] [Abstract][Full Text] [Related]
28. Reduced sensitivity to MDMA-induced facilitation of social behaviour in MDMA pre-exposed rats.
Thompson MR; Callaghan PD; Hunt GE; McGregor IS
Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1013-21. PubMed ID: 18302974
[TBL] [Abstract][Full Text] [Related]
29. Pre-treatment with 3,4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain.
Bull EJ; Porkess V; Rigby M; Hutson PH; Fone KC
J Psychopharmacol; 2006 Mar; 20(2):272-80. PubMed ID: 16510485
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the anxiolytic-like effect of TRH and the response of amygdalar TRHergic neurons in anxiety.
Gutiérrez-Mariscal M; de Gortari P; López-Rubalcava C; Martínez A; Joseph-Bravo P
Psychoneuroendocrinology; 2008 Feb; 33(2):198-213. PubMed ID: 18079066
[TBL] [Abstract][Full Text] [Related]
31. Differential behavioral outcomes of 3,4-methylenedioxymethamphetamine (MDMA-ecstasy) in anxiety-like responses in mice.
Ferraz-de-Paula V; Stankevicius D; Ribeiro A; Pinheiro ML; Rodrigues-Costa EC; Florio JC; Lapachinske SF; Moreau RL; Palermo-Neto J
Braz J Med Biol Res; 2011 May; 44(5):428-37. PubMed ID: 21503414
[TBL] [Abstract][Full Text] [Related]
32. Reduced number of CRF-containing neurons in the central amygdala correlated with enhanced locomotor activity following early postnatal corticosterone treatment in the Wistar rat.
Roskoden T; Hanke J; Yilmazer-Hanke D; Schwegler H
Behav Brain Res; 2005 Dec; 165(2):221-8. PubMed ID: 16144721
[TBL] [Abstract][Full Text] [Related]
33. Persistent cerebrovascular effects of MDMA and acute responses to the drug.
Ferrington L; Kirilly E; McBean DE; Olverman HJ; Bagdy G; Kelly PA
Eur J Neurosci; 2006 Jul; 24(2):509-19. PubMed ID: 16836637
[TBL] [Abstract][Full Text] [Related]
34. Effects of morphine on rat behaviour in the elevated plus maze: the role of central amygdala dopamine receptors.
Rezayof A; Hosseini SS; Zarrindast MR
Behav Brain Res; 2009 Sep; 202(2):171-8. PubMed ID: 19463698
[TBL] [Abstract][Full Text] [Related]
35. Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT 2C receptor responsivity.
Bull EJ; Hutson PH; Fone KC
Neuropharmacology; 2003 Mar; 44(4):439-48. PubMed ID: 12646281
[TBL] [Abstract][Full Text] [Related]
36. Antidepressant-like effects of the delta-opioid receptor agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in an olfactory bulbectomized rat model.
Saitoh A; Yamada M; Yamada M; Takahashi K; Yamaguchi K; Murasawa H; Nakatani A; Tatsumi Y; Hirose N; Kamei J
Brain Res; 2008 May; 1208():160-9. PubMed ID: 18381208
[TBL] [Abstract][Full Text] [Related]
37. Short-term effects of 3,4-methylen-dioxy-metamphetamine (MDMA) on 5-HT(1A) receptors in the rat hippocampus.
Giannaccini G; Betti L; Pirone A; Palego L; Fabiani O; Fabbrini L; Mascia G; Giusti L; Macchia M; Giusiani M; Martini C; Lucacchini A
Neurochem Int; 2007 Dec; 51(8):496-506. PubMed ID: 17602794
[TBL] [Abstract][Full Text] [Related]
38. Interplay between glutamate and serotonin within the dorsal periaqueductal gray modulates anxiety-related behavior of rats exposed to the elevated plus-maze.
Moraes CL; Bertoglio LJ; Carobrez AP
Behav Brain Res; 2008 Dec; 194(2):181-6. PubMed ID: 18675851
[TBL] [Abstract][Full Text] [Related]
39. Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion.
Gurtman CG; Morley KC; Li KM; Hunt GE; McGregor IS
Eur J Pharmacol; 2002 Jun; 446(1-3):89-96. PubMed ID: 12098589
[TBL] [Abstract][Full Text] [Related]
40. Chronic food restriction in young rats results in depression- and anxiety-like behaviors with decreased expression of serotonin reuptake transporter.
Jahng JW; Kim JG; Kim HJ; Kim BT; Kang DW; Lee JH
Brain Res; 2007 May; 1150():100-7. PubMed ID: 17383614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]